Taw Pharma

Taw Pharma is a UK-based specialty pharmaceutical company that focuses on the development, licensing, and commercialization of generic and value-added medicines. The company specializes in complex formulations, particularly within the ophthalmology and sterile injectable sectors. Taw Pharma operates as a Marketing Authorisation Holder (MAH) and collaborates with a global network of manufacturing partners to provide high-quality, cost-effective treatments. Their portfolio includes essential medicines for conditions such as glaucoma and ocular hypertension, aimed at improving patient access to critical therapies. The company is committed to regulatory excellence and maintaining a robust supply chain for the UK healthcare market.